REFERENCES
- Apryshko G.N., Ivanov V.N., Milchakova N.A., Nekhoroshev M.V. (2005) Exp. Oncol., 27(2),94–5.
- Itoh H., Noda H., Amano H., Zhuaug C., Mizuno T., Ito H. (1993) Anticancer Res., 13(6A),2045–52.
- Matsubara K., Xue C., Zhao X., Mori M., Sugawara T., Hirata T. (2005) Int. J. Mol. Med., 15(4),695–9.
- Sogawa K., Matsuda M., Okutani K. (1998) J. Mar. Biotechnol., 6(4),241–3.
- Koyanagi S., Tanigawa N., Nakagawa H., Soeda S., Shimeno H. (2003) Biochem. Pharmacol., 65(2),173–9.
- Aisa Y., Miyakawa Y., Nakazato T. (2005) Am. J. Hematol., 78(1),7–14.
- Teruya T., Konishi T., Uechi S., Tamaki H., Tako M. (2007) Int. J. Biol. Macromol., 41(3),221–6.
- Queiroz K.C.S., Assis C.F., Medeiros V.P. et al.. (2006) Biochemistry (Moscow), 71, N12.
- Huleihel M. et al.. (2002) J. Biochem. Biophys. Methods, 50(N 2–3), 189–200.
- Talyshinsky M. et al.. (2002) Cancer Cell Int., 2, 8.
- Ehresmann D.W. et al.. (1979) Berlin: Gruyter, 293–302.
- Gonzalez M. et al.. (1987) Antimicrob. Agents Chemother., 31, 1388–93.
- Nakashima H. et al.. (1987) Antimicrob Agents Chemother., 31, 1524–8.
- Neushul M. (1990) Hydrobiologia, 205, 99–104.
- Witvrouw M., De Clercq E. (1997) Gen Pharmacol., 29(4), 497–511.
- Fabregas et al.. (1999) Antiviral Research 44, 67–73.
- Torada Hideyuki, Gotou Kentarou (2003) Tetsu- to-Hagane, 89(4), 475–481.
- Gardeva E., Toshkova R., Toncheva-Panova T. (2008) Pharmacoligyonline, 2, 22–4.
- Rabinovitch et al.. (1973) Exp. Cell Res., 77, 323–34.
- Passeti, T.A. (1993). Ph.D. thesis. Biomedical Institute, Sño Paulo.
- Goud S.N. (1999) Toxicology, 135, 69–76.
- Ohyama et al.. (1998) Biol. Pharm. Bull., 21, 1024–1029.
- Haiping Li et al.. (2008) Int. J. of Biol. Macromol., 43, 232–237.
- Yoshizawa Y., Enomoto A., Todho H. (1993) Biosci. Biotech. Biochem., 57, 1862–1866.
- Okai Y., Okai K.-H., Ishizaka S., Yamashita U. (1997) Nutrition and Cancer, 27, 74–79.
- Leung M.Y.K., Liub C., Koon J.C.M., Funga, K.P. (2006) Immunology Letters, 105, 101–114.